Latest filing published 04 Mar 2026 for Aurinia Pharmaceuticals Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Peter Greenleaf: trading record in brief
This profile gathers the share dealings of Peter Greenleaf in Aurinia Pharmaceuticals Inc. Over a trading history stretching from 15 October 2019 to 2 March 2026, the count stands at 14 filings.
On the market, this insider has only ever bought: 1 purchase, €26k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 4 share grants and 9 option exercises.
The record was last updated on 4 March 2026 with an option exercise in Aurinia Pharmaceuticals Inc. The latest purchase dates back some time: it was published 2,582 days ago, on 15 October 2019. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Peter Greenleaf
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 121,579 sharesCommon SharesTSXSEDI:4671099
- 120,342 sharesCommon SharesTSXSEDI:4663974
- 3,877 sharesCommon SharesTSXSEDI:4635052
- 91,185 sharesCommon SharesTSXSEDI:4635056
- 45,191 sharesCommon SharesTSXSEDI:4635058
- 82,603 sharesCommon SharesTSXSEDI:4466202
- 110,095 sharesCommon SharesTSXSEDI:4466206
- 109,168 sharesCommon SharesTSXSEDI:4466201
- 51,507 sharesCommon SharesTSXSEDI:4466204
- 2,938 sharesCommon SharesTSXSEDI:4466200
- 4,886 sharesCommon SharesTSXSEDI:4263223
- 3,104 sharesCommon SharesTSXSEDI:4089987
- 71,330 sharesCommon SharesTSXSEDI:4089985
- 8,328 shares@ CA$4.60100.0% of flowCommon SharesTSXSEDI:3438997Canonical exit: 13 Jan 2020 (T+90)
14 of 14 declarations
